跳至主要内容
临床试验/IRCT201511064166N6
IRCT201511064166N6已完成未知

Visual acuity and central macular thickness in the hemorrhagic choroid neo-vascularization due to age-related macular degeneration with intravitreal Avastin injection compared with intravitreal injection of tissue plasminogen activator with avastin

Tabriz University of Medical Sciences-Vice Chancellor for Research and Technology0 个研究点目标入组 54 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
54

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • hemoragic CNV due to AMD; early onset of symptom in the last month; history of good visual acuity in affected eye
  • Exclusion criteria: history of vitroretinal surgery; uveitis with vitroretinal impairment; corneal disease for example keratoconous, dystrophy and degeneration; any medial hazeness for example vitrous hemorrhage, significant cataract ,...; pathologic myopia; diabetic retinopathy macular edema, retinal detachment, retinal vascular disorder; significant optic nerve injury

排除标准

  • 未提供

研究者

发起方
Tabriz University of Medical Sciences-Vice Chancellor for Research and Technology

相似试验

Effect of intravitral injection of tissue... | 临床试验